4//SEC Filing
White Lauren 4
Accession 0001662579-23-000035
CIK 0001662579other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:44 PM ET
Size
7.1 KB
Accession
0001662579-23-000035
Insider Transaction Report
Form 4
White Lauren
Chief Financial Officer
Transactions
- Award
Common Stock
2023-02-13+26,000→ 31,097 total - Award
Stock Option (Right to Buy)
2023-02-13+125,000→ 125,000 totalExercise: $5.67Exp: 2033-02-12→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 13, 2024.
- [F2]The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 13, 2023.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001864430
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:44 PM ET
- Size
- 7.1 KB